Tourmaline is a late-stage clinical biotechnology company driven by our mission to develop transformative medicines that dramatically improve the lives of patients with life-altering immune diseases. In doing so, we seek to develop assets medicines that have the potential to establish new standards-of-care in areas of high unmet medical need.
Location: United States, New York
Employees: 11-50
Total raised: $75M
Investors 3
| Date | Name | Website |
| 22.06.2023 | Avego | avego.com |
| 25.07.2023 | TCG Crosso... | tcgcrossov... |
| 25.03.2024 | Longitude ... | longitudec... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 19.10.2023 | - | $75M | - |
Mentions in press and media 1
| Date | Title | Description | Source |
| 19.10.2023 | Tourmaline Bio Announces Closing of Merger with Talaris Ther... | - | globenewsw... |